Use of compounds in the treatment of dyskinesia
CA 2499200 A1 · Owner: Hill, Michael · Inventors: Silverdale, Montague; Brotchie, Jonathan; Crossman, Alan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the treatment of dyskinesia with compounds of General Formula (I) such as topiramate. The compound may be topiramate or a derivative thereof. The dyskinesia may be associated with a basil gangliarelated movement disorder such as parkinsonism and may also arise as a sideeffect of other therapeutic agents (e.g. L-DOPA).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 1, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 1, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 1, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.